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Abstract: Genetically modified livestock are farm animals that were subject to 
modification of an endogenous DNA sequence or introduction of exogenous 
DNA into their genome. Genetically modified livestock have great potential 
as models for studies of human diseases, for more efficient meat and dairy 
production, for xenotransplantation, and for production of highly-demanded 
products for human health. Different methods have been defined for obtention 
of genetically modified livestock, with varying efficiencies, limitations and 
advantages. The review aims to describe a brief history on obtention of 
genetically modified livestock, its major hurdles, current approaches for their 
obtention, and future perspectives on the technology. 
Index terms: Farm animals, GMO, Transformation, Transgenesis, 
Recombinant DNA. 
 
UMA VISÃO EM EVOLUÇÃO DA OBTENÇÃO DE ANIMAIS DE 
PRODUÇÃO GENETICAMENTE MODIFICADOS 
 
Resumo: Animais de produção geneticamente modificados são aqueles 
que tiveram uma sequência de DNA endógena modificada ou um DNA 
exógeno introduzido em seu genoma. Animais de produção geneticamente 
modificados apresentam grande potencial como modelo para estudo de 
doenças humanas, para produção mais eficiente de carne e derivados do 
leite, para xenotransplante e para produção de produtos sob grande demanda 
para saúde humana. Diferentes abordagens têm sido descritas para obtenção 
de animais de produção geneticamente modificados, as quais apresentam 
eficiências, vantagens e limitações variáveis. O objetivo da revisão é descrever 
o histórico da obtenção de animais de produção geneticamente modificados, 
os principais obstáculos, abordagens atuais e perspectiva futuras sobre a 
tecnologia. 
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Termos para indexação: Animais de produção, OGM, Transformação, 
Transgênese, DNA recombinante. 
 
 
INTRODUCTION 
The first influence of humankind on livestock genomes was by the 
process of domestication over the past 10,000 years (BRUFORD et al., 2003; 
WIENER; WILKINSON, 2011; LARSON; BURGER, 2013). Another 
significant event that hugely affected the genetic composition of livestock 
populations was the advent of breed formation (WIENER; WILKINSON, 
2011; WANG et al., 2014). From the twentieth century onward, multiple 
developments on animal breeding methodologies led to significant progress on 
livestock quantitative genetic selection (LUSH, 1951; HENDERSON, 1975; 
GIANOLA; ROSA, 2015), despite limited understanding of the genetic basis 
of such traits (HAYES et al., 2013; GIANOLA; ROSA, 2015). More 
importantly, these processes rely on selective breeding to obtain more 
favorable livestock genotypes, and genetic merit is mostly based on 
phenotypes alone, genotyping for major genes, or genomic selection based on 
association between DNA variation and phenotypic data (MEUWISSEN et al., 
2001; HAYES et al., 2013; GIANOLA; ROSA, 2015). 
The first genetically modified mammalian cell was obtained by co- 
incubation of naked DNA and rabbit sperm cells (BRACKETT et al., 1971). 
These sperm cells carrying exogenous DNA were capable of fertilizing eggs and 
stably transmitting it to the embryo genome (BRACKETT et al., 1971). The 
production of the first transgenic animal was performed by introduction of 
simian virus 40 sequences in mouse early embryos, to recapitulate viral- 
induced oncogenesis in newborn mice (JAENISCH; MINTZ, 1974). Curiously, 
these retroviral sequences were epigenetically silenced by DNA methylation, and 
pups were protected from the disease (JAENISCH; MINTZ, 1974; JäHNER 
et al., 1982). However, these reports did not envision the potential of genetic 
modification of the mammalian germ-line, as described below. 
Later efforts demonstrated the feasibility of genetically modifying the 
genome by introduction exogenous DNA (transgene) into mouse early 
embryos (GORDON et al., 1980; BRINSTER et al., 1985; HAMMER et al., 
1985; WALL, 1996, 2001). Under similar experimental conditions, genetically 
modified  livestock  embryos  were  produced  (BREM  et  al., 1985;  HAMMER 
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et  al., 1985), but live animals were obtained years later (Figure 1). At this stage, 
cattle had been considered the most difficult livestock species to modify its 
genome (CLARK, 2002). 
 
Figure 1. Timeline of developments to obtain live-born genetically 
modified livestock. 
 
HR: homologous recombination. ZFN: Zinc finger nucleases. TL: TALENs. 
CC: CRISPR-CAS9. 
 
After these original reports, extensive work has been devoted to 
improving the generation of genetically modified laboratory and livestock 
species (EYESTONE, 1994; CAPECCHI, 1989, 2005; FREITAS et al., 
2012; POLEJAEVA, 2016; ROGERS, 2016; LOTTI et al., 2017). Several 
routes were taken to improve the efficiency and type of genetic modification in 
livestock genomes over almost three decades of intense investigation 
(NIEMANN;  KUES,  2003;  POLEJAEVA,  2016;  ROGERS,  2016). A 
careful analysis of the literature suggested that three arbitrary periods can be 
envisioned during the development of genetically modified livestock (Figure 2). 
The review aimed to describe these three periods by providing a brief history 
on genetically modified livestock production (cattle, pigs, sheep, and goats), its 
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significant hurdles, current approaches for their production, and future 
perspectives. 
 
Figure 2. The three periods of the development of genetically-modified 
livestock. 
 
CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats. HR: 
homologous recombination. ICSI: intracytoplasmatic sperm injection. IVF: 
in vitro fertilization. IVP: in vitro production of preimplantation embryos. 
TALEN: Transcription-Activator Like Endonucleases. ZFN: Zinc Finger 
Nucleases. 
 
THE FIRST PERIOD: INITIAL REPORTS OF GENETICALLY 
MODIFIED LIVESTOCK 
The introduction of exogenous DNA into zygotes was the first approach 
developed that led to the small-scale production of genetically modified 
livestock (EYESTONE, 1994; WALL, 1996, 2001; CLARK, 2002).  This 
procedure, also known as the pronuclear injection (Figure 3A), consists of 
the introduction of transgene copies into zygote pronuclei by ultra-thin 
needles using micromanipulators (GORDON et al., 1980; BREM et al., 
1985; HAMMER et al., 1985). Embryos can be cultured after injection, to 
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identify surviving structures, or transferred immediately to recipient females 
(GORDON et al., 1980; EYESTONE, 1994). Newborn transgenic offspring 
obtained by pronuclear injection are genotyped for transgene integration and the 
number of copies (COUSENS et al., 1994; EYESTONE, 1994, 1999). 
Genetically modified livestock are then raised until puberty and tested for 
germ-line transmission (EYESTONE, 1994, 1999). Founder germ-line 
genetically modified animals can then be propagated by natural mating  or 
assisted reproductive technologies (ART) to increase their numbers 
(EYESTONE et al., 1999; CLARK, 2002; BALDASSARRE et al., 2004). 
Although its simplicity and several proof-of-principle reports, pronuclear 
injection holds several limitations: requires many embryos (e.g., ~150-1,000 
injected zygotes per transgenic animal), embryo survival after injection  is 
relatively low, may generate mosaic animals, and requires germ-line 
transmission testing (EYESTONE, 1994, 1999; CLARK, 2002). Moreover, 
transgenes form tandem head-to-tail sequences upon injection, may hold 
variable copy number integration, and its expression may vary due to position 
effect (PARK, 2007). 
Despite the surmountable number of challenges posed to the obtention of 
genetically modified livestock, such conditions allowed the establishment of 
initial animal models and set the stage for some relevant applications (Table 
1), particularly of pharmaceutical proteins in the milk of goats and cattle 
(MELO et al., 2007). Under the perspective proposed here, these 
developments characterize the first period of obtention of genetically 
modified livestock (Figure 2). 
 
THE SECOND PERIOD: ASSISTED REPRODUCTION 
TECHNOLOGIES AND GENE TARGETING 
The second period is characterized by the substantial development of ART 
(Figure 2), particularly in cattle (HASLER, 2014; LONERGAN; FAIR, 2016), and 
less intensively in small ruminants and pigs (PARAMIO; IZQUIERDO, 2014). 
The in vitro production (IVP) of preimplantation embryos became a large-
scale tool for commercial operations in cattle, where hundreds of thousands 
of offspring are born each year (LONERGAN; FAIR, 2016). It offered an 
attractive approach to generate zygotes for pronuclear injection (EYESTONE, 
1999; BALDASSARRE et al., 2003),  despite  the  lower  developmental 
  
 
 
 
 
 
 
 
 
Table 1. — A survey of key applications of genetically modified livestock. 
 
Major Fields 
Key Applications 
(Period1,2,3) 
Type of Genetic 
Modification 
Method to Obtain 
GM Animals 
References 
 
Animal Models 
Development3 Gene Targeting IVP; SCNT 
Habermann et al., 2007; 
Chen et al., 2015 
Disease3 
Gain-of-Function or 
  Gene Targeting  
PI; SCNT 
Flisikowska et al., 2016; 
    Rogers, 2016  
 
 
 
 
Livestock Production 
Increased Meat Production3 
Myostatin 
Knockout 
IVP; PI; SCNT 
Zhou et al., 2013; Tanihara 
et al., 2016 
Enriched Milk Composition1 Gain-of-Function PI; SCNT 
Bleck et al. 1998; Brophy et 
al., 2003 
Pollness3 Gene Targeting SCNT Tan et al., 2013 
Disease Resistance1-3 
Gain-of-Function or 
Gene Targeting 
SCNT 
Kuroiwa et al., 2004; 
Wu et al., 2015; 
Metabolic Traits1 Gain-of-Function PI Niemann and Kues, 2003 
 
Biopharming 
Human Antibodies2,3 Artificial Chromosome SCNT Kuroiwa et al., 2002 
Pharmaceutical Recombinant 
Proteins1 
Gain-of-Function PI; SCNT 
Schnieke et al., 1997; 
Melo et al., 2007 
 
Xenotransplantation 
Organ Xenografts2,3 
Gain-of-Function or 
Gene Targeting 
SCNT 
Dai et al., 2002; Lai et al., 
2002; Weiss et al., 2009 
Human 
ES-Derived Organs3 
Gene Targeting BI 
Feng et al., 2015; 
Wu et al., 2017 
BI: Blastocyst Injection. GM: Genetically Modified. PI: Pronuclear Injection. SCNT: Somatic Cell Nuclear Transfer. 
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potential of IVP embryos (CLARK, 2002). 
Another major distinction of the second period was the initial efforts on 
gene knockouts by homologous recombination in sheep (MCCREATH et al., 
2000; DENNING et al., 2001), pigs (LAI et al., 2002; DAI et al., 2002; 
PHELPS et al., 2003), and cattle (KUROIWA et al., 2004) (Figure 1). This 
later development was technically-based on pioneered work in the mouse 
(CAPECCHI, 1989, 2005). Several ART-based methods have been described as 
alternative routes to pronuclear injection, to obtain of genetically modified 
livestock (Figure 3), as described below. 
 
Genetically-modified livestock using sperm-mediated methods 
The observation that sperm cells uptake nucleic acid made it as a   new 
method for introduction of foreign DNA into mammalian genomes 
(BRACKETT et al., 1971) (Figure 3A). However, this first report did not 
receive much attention, and sperm-mediated method gained broader attention 
when revisited almost two decades later (LAVITRANO et al., 1989; GANDOLFI, 
2000). Proof-of-principle work in several species demonstrated that this approach 
could be used for obtention of transgenic livestock, even using artificial 
insemination alone (GANDOLFI, 2000; LAVITRANO et al., 2006). 
The process of transgene uptake by sperm cells occurs in two steps (NIU; 
LIANG, 2008). Firstly, it initiates with exogenous DNA binding to sperm 
cells and its internalization. Secondly, transgene copies are integrated into the 
sperm genome in a permanent fashion (NIU; LIANG, 2008). However, the 
application of this method remains limited by growing skepticism due to its low 
reproducibility (GANDOLFI, 2000; EGHBALSAIED et al., 2013). A better 
understanding of the mechanism by which sperm cells uptake DNA molecules 
and the identification of factors that affect this process should receive more 
significant attention. 
An alternative approach to use sperm cells for transgenesis is through 
intracytoplasmatic sperm injection (ICSI) into eggs (Figure 3A), as described in 
the mouse (PERRY et al., 1999; MOISYADI et al., 2009). Physical damage 
compromises sperm motility but facilitates transgene uptake by sperm cells 
(PERRY et al., 2001). Although efficient in mice and primates (KIMURA; 
YANAGIMACHI, 1995; PERRY et al., 1999),  ICSI  is  inefficient  and  not 
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Figure 3. Application of assisted reproduction technologies (ART) 
to obtain genetically modified livestock. Efficiencies are outlined for 
most-widely used ARTs. 
C: cattle. G: goat. M: mouse. S: Sheep. P: Pigs. Pronuclear injection efficiency 
calculated on transgenic animals per injected zygotes. Somatic cell nuclear 
transfer efficiency calculated on live animals by reconstructed oocytes. ES-cell 
derived germ-line chimeras was based on germ-line competent males based 
on those chimeras bred to non-transgenic controls. 
 
 
replicable in livestock,  since  eggs  are  not  readily  activated  by  the  process 
and ICSI embryos have low in vivo developmental potential (GARCÍA-
ROSELLó et al., 2009; LóPEZ-SAUCEDO et al., 2012). Future 
developments on ICSI technology in livestock may motivate to revisit it on 
the future for germ-line modification. 
 
Genetically modified livestock using egg-mediated methods 
Another approach is the delivery of transgenes directly into oocytes or 
eggs (Figure 3A), as described in mouse and cattle systems (CHAN et al., 
1998; PERRY et al., 2001; HOFMANN et al., 2004). Initially, retroviral vectors 
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were used to transfer transgenes to bovine oocytes at high efficiency (CHAN et 
al., 1998). Infection by retroviruses requires replicative cells, mainly using cells 
in metaphase, due to the absence of a nuclear envelope. This fact poses 
metaphase II (MII)-arrested eggs as an attractive cell type (CHAN et al., 
1998; HOFMANN et al., 2004). In cattle, oocyte-mediated transgenesis using 
retrieval vectors was more efficient than pronuclear injection and perivitelline 
injection in zygotes (CHAN et al., 1998). However, transgene silencing was 
observed in newborn transgenic calves (CHAN et al., 1998). 
The use of lentivirus allows more efficient transgene integration and stable 
activity in embryonic cells, thus circumventing silencing (HOFMANN et al., 
2004). Oocyte-mediated transgenesis in mice permitted the introduction of 
larger transgenes (10-170 kilobases) or artificial chromosomes into resulting 
preimplantation embryos and offspring (PERRY et al., 2001). Due to construct 
size, larger transgenes were co-incubated with sperm heads and delivered into 
oocytes during ICSI (PERRY et al., 2001). For livestock, this method could 
now be revisited with the new molecular tools available, as described below. 
 
Genetically modified livestock using somatic cell nuclear transfer 
Animal cloning by somatic cell nuclear transfer (SCNT) gave another 
perspective on the production of genetically modified livestock (Figure 3B). 
Shortly after these initial reports on cloned mammals (WILMUT et al., 1997; 
WAKAYAMA et al., 1998; KATO et al., 1998; MOURA, 2012; KEEFER, 
2015), several species were cloned using transgenic somatic cells (SCHNIEKE et 
al., 1997; CIBELLI et al., 1998; BONDIOLI et al., 2001). The exception to this 
rule was the first report on goat cloning, which already used transgenic donor 
cells (BAGUISI et al., 1999). A significant advantage of this approach was the 
possibility to modify primary cells genetically and select for transgenic cell clones 
before its use for SCNT (HOFMAN et al., 2004; LISAUSKAS et al., 2007). 
Therefore, cloned transgenic cattle are assured for transgene germ- line 
transmission (BORDIGNON et al., 2003). 
There are two limiting factors on production of transgenic cattle using 
SCNT. Firstly, primary cultures of somatic cells have a limited replicative 
capacity (TOMINAGA et al., 2002), thus limiting their expansion and clonal 
selection (MCCREATH et al., 2000; DENNING et al., 2001). This limitation is 
often reduced by usage  of  fetal  cells,  but  multiples  rounds  of  genetic 
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modification  would  require  recovery of cloned fetuses for SCNT (Figure 
3B), in a process often called re-cloning (KUROIWA et al., 2004). Another 
limiting factor is the low efficiency of SCNT to produce viable offspring 
(WILMUT et al., 2002; KEEFER, 2015). Although some protocol 
modifications have increased its efficiency (LOI et al., 2016), more impactful 
improvements are still in demand to increase SCNT efficiency. 
One alternative to increase SCNT efficiency would be to use less 
differentiated cells as donors, which are more amenable for cellular 
reprogramming (CIBELLI et al., 1998a; HOCHEDLINGER; JAENISCH, 
2002). However, progenitor cells or adult stem cells are difficult to establish 
primary cultures (CHEN et al., 2015b) and pluripotent stem cells have not 
been described in livestock (EZASHI et al., 2016; SOTO; ROSS, 2016). 
Thus, the growing understanding of cellular reprogramming may lead to 
attractive strategies to improve SCNT efficiency (YAMANAKA; BLAU, 
2010; JULLIEN et al., 2011; TAKAHASHI; YAMANAKA, 2015; KRAUSE 
et al., 2016; LOI et al., 2016). 
 
Genetically modified livestock using pluripotent stem cells 
The challenge that is presented by the low nuclear reprogramming 
efficiency  during  SCNT  could  be  circumvented by methods using 
pluripotent cells (Figure 3C). The advent of embryonic stem (ES) cells 
revolutionized mouse genetics due to their feasibility to introduce 
exogenous DNA and ease targeted edition of the genome (GOSSLER et 
al., 1986; CAPECCHI, 1989, 2005). The ES-cell phenotype holds two 
hallmark biological features: the potential to form any cell type in the body 
and an unlimited proliferative capacity (EVANS; KAUFFMAN, 1981; 
MARTIN, 1981; WOBUS; BOHELER, 2005; BUEHR et al., 2008). The ES 
cell is functionally equivalent to inner cell mass cells of the blastocyst 
(NAGY et al., 1990), since their introduction into preimplantation embryos 
leads to ES-derived contribution to all mouse tissues, including the germ-line 
(BRADLEY et al., 1984; NAGY et al., 1990; SMITH, 2001). 
These cellular features allow ES cells to be genetically modified by simples 
means, such as electroporation or lipofection when found in single cell 
suspensions (GOSSLER et al., 1986). Transgenic ES cell clones can be isolated 
and readily expanded by negative and-or positive selection (CAPECCHI 
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1989, 2005). Injection of transgenic ES cells into mouse blastocysts generates 
chimeric pups carrying transgenic and non-transgenic cells (GOSSLER et al., 
1986; KOLLER et al., 1989). The mating of chimeric transgenic mice with 
their wild-type counterparts generate transgenic and non-transgenic progeny 
(GOSSLER et al., 1986). Moreover, injection of transgenic mouse ES cells 
into tetraploid preimplantation embryos leads to newborn mice fully-derived 
from ES cells, since tetraploid embryos contribute exclusively to the placenta 
(NAGY et al., 1990, 1993; EGGAN et al., 2002). 
The establishment of livestock ES cells has not been described (EZASHI et 
al., 2016; SOTO; ROSS, 2016). Livestock ES-like cells are readily obtained 
(WHEELER, 1994; BEHBOODI et al., 2013). They show morphology  of 
undifferentiated cells and are prone to spontaneous differentiation in embryos 
bodies or teratoma assays (WHEELER, 1994; CIBELLI et al., 1998b; SAITO 
et al., 2003; BEHBOODI et al., 2013). However, limited ES-derived tissue 
contribution in vivo has been described and no germ-line transmission for 
livestock species (WHEELER, 1994; CIBELLI et al., 1998b; SOTO; ROSS, 
2016). Culture conditions used for human and mouse ES cells do not maintain 
livestock ES pluripotency. Thus identification of signaling pathways that 
contribute to their ES self-renewal is paramount (VERMA et al., 2013; 
EZASHI et al., 2016; SILVA et al., 2017). 
Future research on the more efficient production of livestock tetraploid 
embryos is also advisable (HE et al., 2013; RAZZA et al., 2016), since raising ES-
derived chimeric livestock for germ-line transmission is expected to be 
expensive, due to high maintenance costs and extended generation intervals 
required for germ-line transmission testing. 
An possible attractive alternative to ES technology in livestock was the 
development of induced pluripotent stem (iPS) cells (TAKAHASHI; 
YAMANAKA, 2006; OKITA et al., 2007; WERNIG et al., 2007; OGOREVC 
et al., 2016; SOTO; ROSS, 2016; SILVA et al., 2017). The combined ectopic 
expression of different sets of pluripotency-associated genes triggers cellular 
reprogramming that coverts somatic cells into pluripotent counterparts 
(TAKAHASHI; YAMANAKA, 2006, 2015; KRAUSE et al., 2016). In cattle and 
other livestock, iPS cells show morphology, growth traits and in vitro 
differentiation potential resembling pluripotent cells (OGOREVC et al., 
2016). However, these iPS cells are  dependent  on  ectopic  expression  of 
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reprogramming factors, thus are unlikely to be fully pluripotent, are also 
expected to rely on yet unidentified self-renewal conditions, and their germ- 
line contribution also needs to be demonstrated (SOTO; ROSS, 2016; SILVA 
et al., 2017). Under such circumstances, ES-like can only be destined for 
SCNT (CIBELLI et al., 1998b), albeit at a not very encouraging efficiency. 
 
THE THIRD PERIOD: NOVEL MOLECULAR TOOLS FOR 
GENOME EDITING 
The third period is marked by some progress on construct delivery systems 
and the availability of highly efficient molecular tools for genome editing 
(Figure 2). Although the combination of the targeted locus by homologous 
recombination in somatic cells and its use for SCNT proved to be reliable 
(MCCREATH et al., 2000; DENNING et al., 2001), its low efficiency and 
labor-intensiveness limited its adoption. Therefore, the production of 
genetically-modified livestock, using gene-targeting remained as a costly 
technology. At this stage of its development, the two major limiting factors 
for efficient production of genetically modified livestock remained, namely 
construct delivery and its integration into the genome. Several efforts were 
devoted to meet such demands (WALL, 2002), and are described below 
(Table 2). 
The first attempt to genetically increase construct delivery was made 
using retroviral vectors by co-incubation with cleavage-stage embryos and 
blastocysts (SQUIRE et al., 1989; KIM et al., 1993; HASKELL; BOWEN, 
1995). This approach led to transgenic embryos and fetuses with multiple 
proviral integrations, suggestive of negligible mosaicism and possible germ- 
line contribution (HASKELL; BOWEN, 1995). However, retroviral vectors 
infect only mitotic cells and are subject to silencing in pluripotency cells 
(CHAN et al., 1998). The advent of lentiviral vectors improved transduction 
efficiency, including non-dividing cells and are functional in pluripotent cells 
(HOFMANN et al., 2003, 2004; PARK, 2007). The main disadvantages of 
such vectors are their limited construct size, an inability for genome editing 
and it’s high transduction efficiency is limited to zygotes (PARK, 2007). 
The primary shift brought in the third period came from the availability 
of designer nucleases (PETERSEN; RIEMANN, 2015; WANG, 2015). Three 
nuclease-based systems are now routinely used for livestock genome editing, 
namely zinc finger nucleases (ZFN), transcription activator-like effector 
  
 
 
 
 
 
 
 
 
Table 2. — Association of construct delivery strategies and gene editing tools to obtain genetically modified livestock. 
 
Cell Type Method 
Construct 
Delivery 
Gene Editing 
Tool 
Production of 
Mosaics 
Germ-line 
Transmission 
References 
Sperm AI, IVP CI, VV No Yes Low 
Gandolfi, 2000; Lavitrano et 
al., 2006 
Oocyte or Egg IVP VV No No Moderate Hofmann et al., 2004 
 
 
Zygote 
 
IVV, IVP 
 
MI 
 
No 
 
Yes 
 
Moderate 
 
Eyestone, 1994; Wall, 2001 
 
IVV, IVP 
 
PI, EP, VV 
ZFN, CRISPR, 
TALEN 
 
No 
 
High 
Petersen and Niemann, 
2015 Sato et al., 2016 
 
 
Somatic Cells# 
 
 
SCNT 
 
 
VV, MI, EP, LP 
 
HR, ZFN, 
CRISPR, TALEN 
 
 
No 
 
 
High 
Cibelli et al., 1998; Dai et 
al., 2002; Kuroiwa et a., 
2002; Hofmann et al., 2004; 
Petersen and Niemann, 
2015 
AI: Artificial Insemination. CI: Co-Incubation. CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats. IVP: In Vitro Production of preimplantation embryos. EP: 
Electroporation. HR: Homologous Recombination. IVV: In vivo-produced embryos. LP: Liposomes. MI: Microinjection. PI: Pronuclear Injection. SCNT: Somatic cell Nuclear Transfer. 
TALEN: Transcription-Activator Like Endonucleases. VV: Viral Vectors. ZFN: Zinc Finger Nucleases. 
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nucleases (TALEN), and clustered regularly interspaced short palindromic 
repeats/CRISPR-associated protein 9 (CRISPR/Cas9) (WANG, 2015). 
These nucleases create a double-strand break (DSB) at the desired site in 
the genome, due to its DNA-binding and cleavage domains (PETERSEN; 
RIEMANN, 2015). Gene targeting by HR applies relatively long targeting 
vectors homologous to the gene to be targeted, while the cellular machinery 
performs the HR event (CAPECCHI, 1989, 2005; PETERSEN; RIEMANN, 
2015). The HR approach allows both the generation of gene knock-outs and 
knock-ins, albeit at low efficiency (PETERSEN; RIEMANN, 2015). 
The ZFN technology consists of DNA binding domain formed by at 
least two zinc finger motifs and a cleavage domain of the FokI endonuclease 
(WANG, 2015). The ZFN forms a DSB in the targeted site and the cleavage 
site is repaired by non-homologous end joining (NHEJ) or HR (PETERSEN; 
RIEMANN, 2015). All dominant livestock species have been subject to 
genome editing by ZFN (Figure 1), while more reports are expected to be 
described in the near future. 
The transcription activator-like effector (TALE) consists of 33–35 amino- 
acid repeats with two polymorphisms at positions 12 and 13, which are coined 
as the repeat variable di-residue (RVD) (PETERSEN; RIEMANN, 2015). 
Each RVD binds specifically to one nucleotide of genomic DNA, conferring 
a code for protein-DNA interaction at a single base resolution. Different 
combinations of TALEs allow the targeted recognition of a single genomic 
site (WANG, 2015). A TALE can be linked to a FokI endonuclease to form 
a TALEN, thus allowing targeted edition of the genome (PETERSEN; 
RIEMANN, 2015; WANG, 2015). TALEN DSB sites are repairs by NHEJ 
or HR (PETERSEN; RIEMANN, 2015). Gene-edited livestock animals 
became available shortly after their ZFN-targeted counterparts (Figure 1). 
The most recently developed designer nucleases was the clustered regularly 
interspaced short palindromic repeats / CRISPR-associated protein 9 
(CRISPR/Cas9) system(PETERSEN; RIEMANN, 2015; WANG, 2015). This 
system has a single-guided RNA molecule for targeted sequence recognition 
and the CAS9 nuclease for DNA cleavage (PETERSEN; RIEMANN, 2015). 
Although it holds a similar efficiency to ZFN and TALEN systems, it is easier 
to design, requires  less  labor  and  is more cost-effective than previous methods 
(PETERSEN; RIEMANN, 2015; WANG, 2015). By this fact, gene-edited 
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livestock has been described in recent years with CRISPR/Cas9 (Figure 1), far 
more than the other systems, particularly in pigs. 
These three designer nucleases may be used in somatic cells destined for 
SCNT, but more recently in zygotes (Table 2). This advantage may now 
circumvent the requirement of ART technologies (Figure 1) since in vivo- 
produced zygotes can be transformed by electroporation or possibly other 
relatively simple delivery systems (SATO et al., 2016). The production of 
genetically modified livestock now offers several unprecedented opportunities for 
basic research, and both agricultural and biomedical industries (Table 1). 
Several animal models (PERTERSEN; NIEMANN, 2015; SATO et al., 2016), 
particularly in pigs, became available in the recent years and more are expected 
to be designed in the foreseeable future. This experimental setup seems 
robust, but may be challenging for more sophisticated modifications of the 
genome and for several rounds of gene editing. These may be attractive research 
topics for the next few years. 
 
CONCLUDING REMARKS 
A historical outlook of the obtention of genetically modified livestock was 
provided by an arbitrary division into three distinct periods. Initial efforts to 
produce these animals were met with labor-intensive procedures to retrieve eggs 
or zygotes and to introduce transgenes into them. The development of ARTs, 
particularly IVP and SCNT, increased the availability of injectable zygotes or 
allowed more sophisticated editions of the genome, but their low efficiency 
somewhat counterbalanced their potential. The arrival of new molecular tools 
made genome edition in livestock a reality. Thus, their usage may circumvent 
the dependency on ARTs, which have not reached maturity for most livestock 
species, particularly in pigs. If this trend will stand the test of time, it’s a 
question that will be answered in the years to come. 
 
REFERENCES 
ANZAR, M.; BUHR, M.M. Spontaneous uptake of exogenous DNA by bull spermatozoa. 
Theriogenology, 65: 683-690, 2006. 
160 The evolving picture in... 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
BAGUISI, A.; BEHBOODI, E.; MELICAN, D.T.; POLLOCK, J.S.; DESTREMPES, M.M.; 
CAMMUSO, C.; WILLIAMS, J.L.; NIMS, S.D.; PORTER, C.A.; MIDURA, P.; PALACIOS, 
M.J.; AYRES, S.L.; DENNISTON, R.S.; HAYES, M.L.; ZIOMEK, C.A.; MEADE, H.M.; 
GODKE, R.A.; GAVIN, W.G.; OVERSTRÖM, E.W.; ECHELARD, Y. Production of goats 
by somatic cell nuclear transfer. Nat Biotechnol, 17: 456-461, 1999. 
 
BALDASSARRE, H.; WANG, B.; KAFIDI, N.; GAUTHIER, M.; NEVEU, N.; LAPOINTE, 
J.; SNEEK, L.; LEDUC, M.; DUGUAY, F.; ZHOU, J.F.; LAZARIS, A.; KARATZAS, C.N. 
Production of transgenic goats by pronuclear microinjection of in vitro produced zygotes 
derived from oocytes recovered by laparoscopy. Theriogenology, 59: 831-839, 2003. 
 
BALDASSARRE, H.; WANG, B.; PIERSON, J.; NEVEU, N.; SNEEK, L.; LAPOINTE, 
J.; COTE, F.; KAFIDI, N.; KEEFER, C.L.; LAZARIS, A.; KARATZAS, C.N. Prepubertal 
propagation of transgenic cloned goats by laparoscopic ovum pick-up and in vitro embryo 
production. Cloning Stem Cells, 6: 25-29, 2004. 
 
BEHBOODI, E.; LAM, L.; GAVIN, W.G.; BONDAREVA, A.; DOBRINSKI, I. Goat 
embryonic stem-like cell derivation and characterization. Methods Mol Biol., 1074: 51-67, 
2013. 
 
BEVACQUA, R.J.; FERNANDEZ-MARTÍN, R.; SAVY, V.; CANEL, N.G.; GISMONDI, 
M.I.; KUES, W.A.; CARLSON, D.F.; FAHRENKRUG, S.C.; NIEMANN, H.; TABOGA, 
O.A.; FERRARIS, S.; SALAMONE, D.F. Efficient edition of the bovine PRNP prion gene 
in somatic cells and IVF embryos using the CRISPR/Cas9 system. Theriogenology, 86: 
1886-1896, 2016. 
 
BLECK, G.T.; WHITE, B.R.; MILLER, D.J.; WHEELER, M.B. Production of bovine alpha- 
lactalbumin in the milk of transgenic pigs. J Anim Sci., 76: 3072-3078, 1998. 
 
BONDIOLI, K.; RAMSOONDAR, J.; WILLIAMS, B.; COSTA, C.; FODOR, W. Cloned 
pigs generated from cultured skin fibroblasts derived from a H-transferase transgenic boar. 
Mol Reprod Dev., 60: 189-195, 2001. 
 
BORDIGNON, V.; KEYSTON, R.; LAZARIS, A.; BILODEAU, A.S.; PONTES, J.H.; 
ARNOLD, D.; FECTEAU, G.; KEEFER, C.; SMITH, L.C. Transgene expression of green 
fluorescent protein and germ line transmission in cloned calves derived from in vitro- 
transfected somatic cells. Biol. Reprod., 68: 2013-2023, 2003. 
 
BRACKETT, B.G.; BARANSKA, W.; SAWICKI, W.; KOPROWSKI, H. Uptake of 
heterologous genome by mammalian spermatozoa and its transfer to ova through fertilization. 
PNAS, 68: 353-357, 1971. 
 
BRADLEY, A.; EVANS, M.; KAUFMAN, M.H.; ROBERTSON, E. Formation of germ– 
line chimaeras from embryo–derived teratocarcinoma cell lines. Nature, 309: 255–256, 
1984. 
161 M.T. MOURA et al. 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
BRINSTER, R.L.; CHEN, H.Y.; TRUMBAUER, M.E.; YAGLE, M.K.; PALMITER, R.D. 
Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting 
eggs. PNAS, 82: 4438-4442, 1985. 
 
BROPHY, B.; SMOLENSKI, G.; WHEELER, T.; WELLS, D.; L’HUILLIER, P.; LAIBLE, 
G. Cloned transgenic cattle produce milk with higher levels of beta-casein and kappa-casein. 
Nat Biotechnol, 21: 157-162, 2003. 
 
BRUFORD, M.W.; BRADLEY, D.G.; LUIKART, G. DNA markers reveal the complexity of 
livestock domestication. Nat Rev Genet, 4: 900-910, 2003. 
 
BUEHR, M.; MEEK, S.; BLAIR, K.; YANG, J.; URE, J.; SILVA, J.; MCLAY, R.; HALL, J.; 
YING, Q.L.; SMITH, A. Capture of authentic embryonic stem cells from rat blastocysts. 
Cell, 135: 1287-1298, 2008. 
 
CAPECCHI, M.R. The new mouse genetics: altering the genome by gene targeting. Trend 
Genet, 5: 70-76, 1989. 
 
CAPECCHI, M.R. Gene targeting in mice: functional analysis of the mammalian genome 
for the twenty-first century. Nat Rev Genet, 6: 507-512, 2005. 
 
CHAN, A.W.; HOMAN, E.J.; BALLOU, L.U.; BURNS, J.C.; BREMEL, R.D. Transgenic 
cattle produced by reverse-transcribed gene transfer in oocytes. PNAS, 95: 14028-14033, 
1998. 
 
CHEN, F.;  WANG, Y.;  YUAN, Y.;  ZHANG, W.;  REN, Z.; JIN, Y.;  LIU, X.; XIONG, Q.; 
CHEN, Q.; ZHANG, M.; LI, X.; ZHAO, L.; LI, Z.; WU, Z.; ZHANG, Y.; HU, F.; HUANG, 
J.; LI, R.; DAI, Y.  Generation of  B cell-deficient pigs by highly efficient CRISPR/Cas9- 
mediated gene targeting. J Genet Genomics, 42: 437-444, 2015A. 
 
CHEN, X.; YE, S.; YING, Q.L. Stem cell maintenance by manipulating signaling pathways: 
past, current and future. BMB Rep, 48: 668-676, 2015B. 
 
CIBELLI, J.B.; STICE, S.L.; GOLUEKE, P.J.; KANE, J.J.; JERRY, J.; BLACKWELL, C.; 
PONCE DE LEóN, F.A.; ROBL, J.M. Cloned transgenic calves produced from nonquiescent 
fetal fibroblasts. Science, 280: 1256-1258, 1998. 
 
CIBELLI, J.B.; STICE, S.L.; GOLUEKE, P.J.; KANE, J.J.; JERRY, J.; BLACKWELL, C.; 
PONCE DE LEóN, F.A.; ROBL, J.M. Transgenic bovine chimeric offspring produced from 
somatic cell-derived stem-like cells. Nat Biotech, 16: 642-646, 1998. 
 
CLARK, A.J. Generation of transgenic livestock by pronuclear injection. Methods Mol 
Biol, 180: 273-287, 2002. 
 
COUSENS, C.; CARVER, A.S.; WILMUT, I.; COLMAN, A.; GARNER, I.; O’NEILL, 
G.T. Use of PCR-based methods for selection of integrated transgenes in preimplantation 
embryos. Mol Reprod Dev, 39: 384-391, 1994. 
162 The evolving picture in... 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
DAI, Y.; VAUGHT, T.D.; BOONE, J.; CHEN, S.H.; PHELPS, C.J.; BALL, S.; MONAHAN, 
J.A.; JOBST, P.M.; MCCREATH, K.J.; LAMBORN, A.E.; COWELL-LUCERO, J.L.; 
WELLS, K.D.; COLMAN, A.; POLEJAEVA, I.A.; AYARES, D.L. Targeted disruption of 
the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol, 20: 251-255, 2002. 
 
DENNING, C.; DICKINSON, P.; BURL, S.; WYLIE, D.; FLETCHER, J.; CLARK, A.J. 
Gene targeting in primary fetal fibroblasts from sheep and pig. Cloning and Stem Cells, 3: 
221-231, 2001. 
 
EGGAN, K.; RODE, A.; JENTSCH, I.; SAMUEL, C.; HENNEK, T.; TINTRUP, H.; 
ZEVNIK, B.; ERWIN, J.; LORING, J.; JACKSON-GRUSBY, L.; SPEICHER, M.R.; 
KUEHN, R.; JAENISCH, R. Male and female mice derived from the same embryonic stem 
cell clone by tetraploid embryo complementation. Nat Biotechnol, 20: 455-459, 2002. 
 
EGHBALSAIED, S.; GHAEDI, K.; LAIBLE, G.; HOSSEINI, S.M.; FOROUZANFAR, 
M.; HAJIAN, M.; OBACK, F.; NASR-ESFAHANI, M.H.; OBACK, B. Exposure to DNA 
is insufficient for in vitro transgenesis of live bovine sperm and embryos. Reproduction, 
145: 97-108, 2003. 
 
EVANS, M.J.; KAUFMAN, M.H. Establishment in culture of pluripotential cells from 
mouse embryos. Nature, 292: 154–156, 1981. 
 
EYESTONE, W.H. Challenges and progress in the production of transgenic cattle. Reprod 
Fert Dev, 6: 647-652, 1994. 
 
EYESTONE, W.H. Production and breeding of transgenic cattle using in vitro embryo 
production technology. Theriogenology, 51: 509-517, 1999. 
 
EZASHI, T.; YUAN, Y.; ROBERTS, R.M. Pluripotent Stem Cells from Domesticated 
Mammals. Ann Rev Anim Biosciences, 4: 223-253, 2016. 
 
FENG, W.; DAI, Y.; MOU, L.; COOPER, D.K.; SHI, D.; CAI, Z. The potential of the 
combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from 
chimaeric pigs. Int J Mol Sci, 16: 6545-6556, 2015. 
 
FLISIKOWSKA, T.; KIND, A.; SCHNIEKE, A. Pigs as models of human cancers. 
Theriogenology, 86: 433-437, 2016. 
 
FREITAS, V.J.F.; SEROVA, I.A.; MOURA, R.R.; ANDREEVA, L.E.; MELO, L.M.; 
TEIXEIRA, D.I.A.; PEREIRA, A.F.; LOPES-JR, E.S.; DIAS, L.P.B.; NUNES-PINHEIRO, 
D.C.S.; SOUSA, F.C.; ALCâNTARA-NETO, A.S.; ALBUQUERQUE, E.S.; MELO, C.H.S.; 
RODRIGUES, V.H.V.; BATISTA, R.I.T.P.; DVORYANCHIKOV, G.A.; SEROV, O.L. The 
establishment of two transgenic goat lines for mammary gland hG-CSF expression. Small 
Ruminant Research, 105: 105-113, 2012. 
 
GANDOLFI, F. Sperm-mediated transgenesis. Theriogenology, 53: 127-137, 2000. 
163 M.T. MOURA et al. 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
GARCÍA-ROSELLÓ, E.; GARCÍA-MENGUAL, E.; COY, P.; ALFONSO, J.; SILVESTRE, 
M.A. Intracytoplasmic sperm injection in livestock species: an update. Reprod Domest 
Anim, 44: 143-151, 2009. 
 
GIANOLA, D.; ROSA, G.J. One hundred years of statistical developments in animal 
breeding. Annu Rev Anim Biosci., 3: 19-56, 2015. 
 
GIL, M.A.; CUELLO, C.; PARRILLA, I.; VAZQUEZ, J.M.; ROCA, J.; MARTINEZ, E.A. 
Advances in swine in vitro embryo production technologies. Reprod Domest Anim, 45 
(Supplement 2): 40-48, 2010. 
 
GORDON, J.W.; SCANGOS, G.A.; PLOTKIN, D.J.; BARBOSA, J.A.; RUDDLE, F.H. 
Genetic transformation of mouse embryos by microinjection of purified DNA. PNAS, 77: 
7380-7384, 1980. 
 
GOSSLER, A.; DOETSCHMAN, T.; KORN, R.; SERFLING, E.; KEMLER, R. Transgenesis 
by means of blastocyst-derived embryonic stem cell lines. PNAS, 83: 9065-9069, 1986. 
 
HABERMANN, F.A.; WUENSCH, A.; SINOWATZ, F.; WOLF, E. Reporter genes for 
embryogenesis research in livestock species. Theriogenology, 68: S116-124, 2007. 
 
HAMMER, R.E.; PURSEL, V.G.; REXROAD, C.E. JR; WALL, R.J.; BOLT, D.J.; EBERT, 
K.M.; PALMITER, R.D.; BRINSTER, R.L. Production of transgenic rabbits, sheep and pigs 
by microinjection. Nature, 315: 680-683, 1985. 
 
HASKELL, R.E.; BOWEN, R.A. Efficient production of transgenic cattle by retroviral 
infection of early embryos. Mol Reprod Dev, 40: 386-390, 1995. 
 
HAYES, B.J.; LEWIN, H.A.; GODDARD, M.E. The future of livestock breeding: genomic 
selection for efficiency, reduced emissions intensity, and adaptation. Trends Genet, 29: 206- 
214, 2013. 
 
HE, W.; KONG, Q.; SHI, Y.; XIE, B.; JIAO, M.; HUANG, T.; GUO, S.; HU, K.; LIU, Z. 
Generation and developmental characteristics of porcine tetraploid embryos and tetraploid/ 
diploid chimeric embryos. Genomics Proteomics Bioinformatics, 11: 327-333, 2013. 
 
HENDERSON, C.R. Best linear unbiased estimation and prediction under a selection model. 
Biometrics, 31: 423-447, 1975. 
 
HOCHEDLINGER, K.; JAENISCH, R. Nuclear transplantation: lessons from frogs and 
mice. Curr Opin Cell Biol, 14: 741-748, 2002. 
 
HOFMANN, A.; KESSLER, B.; EWERLING, S.; WEPPERT, M.; VOGG, B.; LUDWIG, 
H.; STOJKOVIC, M.; BOELHAUVE, M.; BREM, G.; WOLF, E.; PFEIFER, A. Efficient 
transgenesis in farm animals by lentiviral vectors. EMBO Reports, 4: 1054-1060, 2003. 
164 The evolving picture in... 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
HOFMANN, A.; ZAKHARTCHENKO, V.; WEPPERT, M.; SEBALD, H.; 
WENIGERKIND, H.; BREM, G.; WOLF, E.; PFEIFER, A. Generation of transgenic cattle 
by lentiviral gene transfer into oocytes. Biol Reprod, 71: 405-409, 2004. 
 
JAENISCH, R.; MINTZ, B. Simian virus 40 DNA sequences in DNA of healthy adult mice 
derived from preimplantation blastocysts injected with viral DNA. PNAS, 71: 1250-1254, 
1974. 
 
JäHNER, D.; STUHLMANN, H.; STEWART, C.L.; HARBERS, K.; LÖHLER, J.; SIMON, 
I.; JAENISCH, R. De novo methylation and expression of retroviral genomes during mouse 
embryogenesis. Nature, 298: 623-628, 1982. 
 
JULLIEN, J.; PASQUE, V.; HALLEY-STOTT, R.P.; MIYAMOTO, K.; GURDON, J.B. 
Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process? Nat 
Rev Mol Cell Biol, 12: 453-459, 2011. 
 
KEEFER, C.L. Artificial cloning of domestic animals. PNAS, 112:8874-8878, 2015. 
 
KIM, T.; LEIBFRIED-RUTLEDGE, M.L.; FIRST, N.L. Gene transfer in bovine blastocysts 
using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus 
envelopes. Mol Reprod Dev, 35: 105-113, 1993. 
 
KIM, G.A.; LEE, E.M.; JIN, J.X.; LEE, S.; TAWEECHAIPAISANKUL, A.; HWANG, J.I.; 
ALAM, Z.; AHN, C.; LEE, B.C. Generation of CMAHKO/GTKO/shTNFRI-Fc/HO-1 
quadruple gene modified pigs. Transgenic Res, 26: 435-445, 2017. 
 
KIMURA, Y.; YANAGIMACHI, R. Intracytoplasmic sperm injection in the mouse. Biol 
Reprod, 52: 709-720, 1995. 
 
KOLLER, B.H.; HAGEMANN, L.J.; DOETSCHMAN, T.; HAGAMAN, J.R.; HUANG, S.; 
WILLIAMS, P.J.; FIRST, N.L.; MAEDA, N.; SMITHIES, O. Germ-line transmission of a 
planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous 
recombination in embryonic stem cells. PNAS, 86: 8927-8931, 1989. 
 
KRAUSE, M.N.; SANCHO-MARTINEZ, I.; IZPISUA BELMONTE, J.C. Understanding 
the molecular mechanisms of reprogramming. Biochemical and Biophysical Research 
Communications, 473: 693-697, 2016. 
 
KUROIWA, Y.; KASINATHAN, P.; CHOI, Y.J.; NAEEM, R.; TOMIZUKA, K.; SULLIVAN, 
E.J.; KNOTT, J.G.; DUTEAU, A.; GOLDSBY, R.A.; OSBORNE, B.A.; ISHIDA, I.; ROBL, 
J.M. Cloned transchromosomic calves producing human immunoglobulin. Nat Biotech, 20: 
889-894, 2002. 
 
KUROIWA, Y.; KASINATHAN, P.; MATSUSHITA, H.; SATHIYASELAN, J.; SULLIVAN, 
E.J.; KAKITANI, M.; TOMIZUKA, K.; ISHIDA, I.; ROBL, J.M. Sequential targeting of the 
genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet, 36: 775-780, 
2004. 
165 M.T. MOURA et al. 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
LAI, L.; KOLBER-SIMONDS, D.; PARK, K.W.; CHEONG, H.T.; GREENSTEIN, J.L.; IM, 
G.S.; SAMUEL, M.; BONK, A.; RIEKE, A.; DAY, B.N.; MURPHY, C.N.; CARTER, D.B.; 
HAWLEY, R.J.; PRATHER, R.S. Production of alpha-1,3-galactosyltransferase knockout 
pigs by nuclear transfer cloning. Science, 295: 1089-1092, 2002. 
 
LARSON, G.; BURGER, J. A population genetics view of animal domestication. Trends 
Genet, 29: 197-205, 2013. 
 
LAVITRANO, M.; CAMAIONI, A.; FAZIO, V.M.; DOLCI, S.; FARACE, M.G.; 
SPADAFORA, C. Cell, 57: 717-723, 1989. 
 
LAVITRANO, M.; BUSNELLI, M.; CERRITO, M.G.; GIOVANNONI, R.; MANZINI, S.; 
VARGIOLU, A. Sperm-mediated gene transfer. Reprod Fertil Dev, 18: 19-23, 2006. 
 
LISAUSKAS, S.F.; RECH, E.L.; ARAGÃO, F.J. Characterization of transgene integration 
loci in transformed Madin Darby bovine kidney cells. Cloning Stem Cells, 9: 456-460, 
2007. 
 
LOI, P.; IUSO, D.; CZERNIK, M.; OGURA, A. A New, Dynamic Era for Somatic Cell 
Nuclear Transfer? Trends Biotech, 34: 791-797, 2016. 
 
LONERGAN, P.; FAIR, T. Maturation of Oocytes in Vitro. Annu Rev Anim Biosci, 4: 
255-268, 2016. 
 
LóPEZ-SAUCEDO, J.; PARAMIO-NIETO, M.T.; FIERRO, R.; PIñA-AGUILAR, R.E. 
Intracytoplasmic sperm injection (ICSI) in small ruminants. Anim Reprod Sci, 133: 129- 
138, 2012. 
 
LOTTI, S.N.; POLKOFF, K.M.; RUBESSA, M.; WHEELER, M.B. Modification of the 
Genome of Domestic Animals. Anim Biotechnol, 28: 198-210, 2017. 
 
LUSH, J.L.The impact of genetics on animal breeding. J Anim Sci, 10: 311-321, 1951. 
 
MARTIN, G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in 
medium conditioned by teratocarcinoma stem cells. PNAS, 78: 7634-7638, 1981. 
 
MCCREATH, K.J.; HOWCROFT, J.; CAMPBELL, K.H.; COLMAN, A.; SCHNIEKE, 
A.E.; KIND, A.J. Production of gene-targeted sheep by nuclear transfer from cultured 
somatic cells. Nature, 405: 1066-1069, 2000. 
 
MELO, E.O.; CANAVESSI, A.M.; FRANCO, M.M.; RUMPF, R. Animal transgenesis: state 
of the art and applications. J Appl Genet, 48: 47-61, 2007. 
 
MEUWISSEN, T.H.; HAYES, B.J.; GODDARD, M.E. Prediction of total genetic value 
using genome-wide dense marker maps. Genetics, 157: 1819-1829, 2001. 
166 The evolving picture in... 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
MOGHADDASSI, S.; EYESTONE, W.; BISHOP, C.E. TALEN-mediated modification of 
the bovine genome for large-scale production of human serum albumin. PLoS One, 9: 
e89631, 2014. 
 
MOISYADI, S.; KAMINSKI, J.M.; YANAGIMACHI, R. Use of intracytoplasmic sperm 
injection (ICSI) to generate transgenic animals. Comp Immunol Microbiol Infect Dis, 32: 
47-60, 2009. 
 
MOURA, M.T. Pluripotency and cellular reprogramming. Anais da Academia 
Pernambucana de Ciência Agronômica, 8: 138-168, 2012. 
 
NAGY, A.; GóCZA, E.; DIAZ, E.M.; PRIDEAUX, V.R.; IVÁNYI, E.; MARKKULA, 
M.; ROSSANT, J. Embryonic stem cells alone are able to support fetal development in the 
mouse. Development, 110: 815-821, 1990. 
 
NAGY, A.; ROSSANT, J.; NAGY, R.; ABRAMOW-NEWERLY, W.; RODER, J.C. Derivation 
of completely cell culture-derived mice from early-passage embryonic stem cells. PNAS, 90: 
8424-8428, 1993. 
 
NI, W.; QIAO, J.; HU, S.; ZHAO, X.; REGOUSKI, M.; YANG, M.; POLEJAEVA, I.A.; 
CHEN, C. Efficient gene knockout in goats using CRISPR/Cas9 system. PLoS One, 9: 
e106718, 2014. 
 
NIEMANN, H.; KUES, W.A. Application of transgenesis in livestock for agriculture and 
biomedicine. Anim Reprod Sci, 79: 291-317, 2003. 
 
NIU, Y.; LIANG, S. Progress in gene transfer by germ cells in mammals. J Genet Genomics, 
35: 701-714, 2008. 
 
OGOREVC, J.; OREHEK, S.; DOVč, P. Cellular reprogramming in farm animals: an 
overview of iPSC generation in the mammalian farm animal species. J Anim Sci Biotech, 
7: 10, 2016. 
 
OKITA, K.; ICHISAKA, T.; YAMANAKA, S. Generation of germline–competent 
induced pluripotent stem cells. Nature, 448: 313-317, 2007. 
 
PARAMIO, M.T.; IZQUIERDO, D. Current status of in vitro embryo production in sheep 
and goats. Reprod Domest Anim, 49 (Supplement 4): 37-48, 2014. 
 
PARK, F. Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics., 
31: 159-73, 2007. 
 
PEREYRA-BONNET, F.; FERNÁNDEZ-MARTÍN, R.; OLIVERA, R.; JARAZO, J.; 
VICHERA, G.; GIBBONS, A.; SALAMONE, D. A unique method to produce transgenic 
embryos in ovine, porcine, feline, bovine and equine species. Reprod Fert Dev, 20: 741-749, 
2008. 
167 M.T. MOURA et al. 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
PERRY, A.C.; WAKAYAMA, T.; KISHIKAWA, H.; KASAI, T.; OKABE, M.; TOYODA, 
Y.;  YANAGIMACHI, R. Mammalian transgenesis by intracytoplasmic sperm injection. 
Science, 284: 1180-1183, 1999. 
 
PERRY, A.C.; ROTHMAN, A.; DE LAS HERAS, J.I.; FEINSTEIN, P.; MOMBAERTS, P.; 
COOKE, H.J.; WAKAYAMA, T. Efficient metaphase II transgenesis with different transgene 
archetypes. Nat Biotechnol, 19: 1071-1073, 2001. 
 
PETERSEN, B.; NIEMANN, H. Molecular scissors and their application in genetically 
modified farm animals. Transgenic Res, 24: 381-396, 2015. 
 
PHELPS, C.J.;  KOIKE, C.; VAUGHT,  T.D.;  BOONE, J.;  WELLS, K.D.;  CHEN,  S.H.; 
BALL, S.; SPECHT, S.M.; POLEJAEVA, I.A.; MONAHAN, J.A.; JOBST, P.M.;  SHARMA, 
S.B.; LAMBORN, A.E.; GARST, A.S.; MOORE, M.; DEMETRIS, A.J.; RUDERT, W.A.; 
BOTTINO, R.; BERTERA, S.; TRUCCO,  M.; STARZL, T.E.;  DAI, Y.;  AYARES, D.L. 
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299: 411-414, 2003. 
 
POLEJAEVA, I.A.; RUTIGLIANO, H.M.; WELLS, K.D. Livestock in biomedical research: 
history, current status and future prospective. Reprod Fertil Dev, 28: 112-124, 2016. 
 
RAZZA, E.M.; SATRAPA, R.A.; EMANUELLI, I.P.; BARROS, C.M.; NOGUEIRA, M.F. 
Screening of biotechnical parameters for production of bovine inter-subspecies embryonic 
chimeras by the aggregation of tetraploid Bos indicus and diploid crossbred Bos taurus 
embryos. Reprod Biol, 16: 34-40, 2016. 
 
ROGERS, C.S. Genetically engineered livestock for biomedical models. Transgenic Res, 
25: 345-359, 2016. 
 
SAITO, S.; SAWAI, K.; UGAI, H.; MORIYASU, S.; MINAMIHASHI, A.; YAMAMOTO, 
Y.; HIRAYAMA, H.; KAGEYAMA, S.; PAN, J.; MURATA, T.; KOBAYASHI, Y.; OBATA, 
Y.; YOKOYAMA, K.K. Generation of cloned calves and transgenic chimeric embryos from 
bovine embryonic stem-like cells. Biochem Biophys Res Commun, 309: 104-113, 2003. 
 
SATO, M.; OHTSUKA, M.; WATANABE, S.; GURUMURTHY, C.B. Nucleic acids delivery 
methods for genome editing in zygotes and embryos: the old, the new, and the old-new. Biol 
Direct, 11: 16, 2016. 
 
SCHNIEKE, A.E.; KIND, A.J.; RITCHIE, W.A.; MYCOCK, K.; SCOTT, A.R.; RITCHIE, 
M.; WILMUT, I.; COLMAN, A.; CAMPBELL, K.H. Human factor IX transgenic sheep 
produced by transfer of nuclei from transfected fetal fibroblasts. Science, 278: 2130-2133, 
1997. 
 
SILVA, P.G.C.; MOURA, M.T.; BRAGA, V.A.A.; FERREIRA-SILVA, J.C.; NASCIMENTO, 
P.S.; CANTANHêDE, L.F.; CHAVES, M.S.; OLIVEIRA, M.A.L. Atividade dos genes 
relacionados à pluripotência em ovinos. Med Vet (UFRPE), v, 2017. 
168 The evolving picture in... 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
SMITH, K.R. Sperm cell mediated transgenesis: a review. Anim Biotech, 10: 1-13, 1999. 
 
SMITH, A.G. Embryo–derived stem cells: of mice and men. Annu Rev Cell Dev Biol, 17: 
435–462, 2001. 
 
SOTO, D.A.; ROSS, P.J. Pluripotent stem cells and livestock genetic engineering. Transgenic 
Res, 25: 289-306, 2016. 
 
SQUIRE, K.R.; EMBRETSON, J.E.; FIRST, N.L. In vitro testing of a potential retroviral 
vector for producing transgenic livestock. Am J Vet Res, 50: 1423-1427, 1989. 
 
TAKAHASHI, K.; YAMANAKA, S. A developmental framework for induced pluripotency. 
Development, 142: 3274-3285, 2015. 
 
TAN, W.; CARLSON, D.F.; LANCTO, C.A.; GARBE, J.R.; WEBSTER, D.A.; HACKETT, 
P.B.;  FAHRENKRUG,  S.C.  Efficient nonmeiotic allele introgression in livestock using 
custom endonucleases. PNAS, 110: 16526-16531, 2013. 
 
TANG, L.; GONZÁLEZ, R.; DOBRINSKI, I. Germline modification of domestic animals. 
Anim Reprod, 12: 93-104, 2015. 
 
TANIHARA, F.; TAKEMOTO, T.; KITAGAWA, E.; RAO, S.; DO, L.T.; ONISHI, A.; 
YAMASHITA, Y.; KOSUGI, C.; SUZUKI, H.; SEMBON, S.; SUZUKI, S.; NAKAI,  
M.; HASHIMOTO, M.; YASUE, A.; MATSUHISA, M.; NOJI, S.; FUJIMURA, T.; 
FUCHIMOTO, D.; OTOI, T. Somatic cell reprogramming-free generation of  genetically 
modified pigs. Sci Adv, 2: e1600803, 2016. 
 
TOMINAGA, K.; OLGUN, A.; SMITH, J.R.; PEREIRA-SMITH, O.M. Genetics of cellular 
senescence. Mech Ageing Dev, 123: 927-936, 2002. 
 
VERMA, V.; HUANG, B.; KALLINGAPPA, P.K.; OBACK, B. Dual kinase inhibition 
promotes pluripotency in finite bovine embryonic cell lines. Stem Cells Dev, 22: 1728-1742, 
2013. 
 
WALL, R.J. Pronuclear microinjection. Cloning Stem Cells, 3: 209-220, 2001. 
WALL, R.J. New gene transfer methods. Theriogenology, 57: 189-201, 2002. 
WALL, R.J. Transgenic livestock: progress and prospects for the future. Theriogenology, 
45: 57-68, 1996. 
 
WANG, G.D.; XIE, H.B.; PENG, M.S.; IRWIN, D.; ZHANG, Y.P. Domestication genomics: 
evidence from animals. Annu Rev Anim Biosci, 2: 65-84, 2014. 
 
WANG, Z. Genome engineering in cattle: recent technological advancements. Chromosome 
Res., 23: 17-29, 2015. 
169 M.T. MOURA et al. 
Anais da Academia Pernambucana de Ciência Agronômica, vols. 13/14, p.145-169, 2016/2017. 
 
 
WEISS, E.H.; LILIENFELD, B.G.; MÜLLER, S.; MÜLLER, E.; HERBACH, N.; KESSLER, 
B.; WANKE, R.; SCHWINZER, R.; SEEBACH, J.D.; WOLF, E.; BREM, G. HLA-E/human 
beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural 
killer cell cytotoxicity. Transplantation, 87: 35-43, 2009. 
 
WERNIG, M.; MEISSNER, A.; FOREMAN, R.; BRAMBRINK, T.; KU, M.; 
HOCHEDLINGER, K.; BERNSTEIN, B.E.; JAENISCH R. In vitro reprogramming of 
broblasts into a pluripotent ES–cell–like state. Nature, 448: 318-324, 2007. 
 
WHEELER, M.B. Development and validation of swine embryonic stem cells: a review. 
Reprod Fertil Dev, 6: 563-568, 1994. 
 
WIENER, P.; WILKINSON, S. Deciphering the genetic basis of animal domestication. 
Proc Biol Sci, 278: 3161-3170.,2011. 
 
WOBUS, A.M.; BOHELER, K.R. Embryonic stem cells: prospects for developmental 
biology and cell therapy. Phys Rev, 85: 635-678, 2005. 
 
WU, H.; WANG, Y.; ZHANG, Y.; YANG, M.; LV, J.; LIU, J.; ZHANG, Y. TALE nickase- 
mediated SP110 knockin endows cattle with increased resistance to tuberculosis. PNAS, 112: 
E1530-1539, 2015. 
 
WU, J.; PLATERO-LUENGO, A.; SAKURAI, M.; SUGAWARA, A.; GIL, M.A.; 
YAMAUCHI, T.; SUZUKI, K.; BOGLIOTTI, Y.S.; CUELLO, C.; MORALES VALENCIA, 
M.; OKUMURA, D.; LUO, J.; VILARIñO, M.; PARRILLA, I.; SOTO, D.A.; MARTINEZ, 
C.A.; HISHIDA, T.; SÁNCHEZ-BAUTISTA, S.; MARTINEZ-MARTINEZ, M.L.; WANG, 
H.; NOHALEZ, A.; AIZAWA, E.; MARTINEZ-REDONDO, P.; OCAMPO, A.; REDDY, 
P.; ROCA, J.; MAGA, E.A.; ESTEBAN, C.R.; BERGGREN, W.T.; NUñEZ DELICADO, E.; 
LAJARA, J.; GUILLEN, I.; GUILLEN, P.; CAMPISTOL, J.M.; MARTINEZ, E.A.; ROSS, 
P.J.; IZPISUA BELMONTE, J.C. Interspecies Chimerism with Mammalian Pluripotent Stem 
Cells. Cell, 168: 473-486, 2017. 
 
YAMANAKA, S.; BLAU, H.M. Nuclear reprogramming to a pluripotent state by three 
approaches. Nature, 465: 704-712, 2010. 
 
ZHOU, Z.R.; ZHONG, B.S.; JIA, R.X.; WAN, Y.J.; ZHANG, Y.L.; FAN, Y.X.; WANG, 
L.Z.; YOU, J.H.; WANG, Z.Y.; WANG, F. Production of myostatin-targeted goat by nuclear 
transfer from cultured adult somatic cells. Theriogenology, 79: 225-233, 2013. 
